Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Substituted 3 Heteroaroylamino Propionic Acid Derivatives And Their Use As Pharmaceuticals
Abstract: 1030405060The present invention relates to compounds of the formula (I) wherein A D E L G R R R R and R have the meanings indicated in the claims which are valuable pharmaceutical active compounds. They are inhibitors of the protease cathepsin A and are useful for the treatment of diseases such as atherosclerosis heart failure renal diseases liver diseases or inflammatory diseases for example. The invention furthermore relates to processes for the preparation of the compounds of the formula I their use and pharmaceutical compositions comprising them.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
21 June 2013
Publication Number
02/2015
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
patent@depenning.com
Parent Application
Applicants
SANOFI
54 rue La Boétie
F 75008 Paris
Inventors
1. RUF Sven
c/o Sanofi Aventis Deutschland GmbH
65926 Frankfurt am Main
2. SADOWSKI Thorsten
c/o Sanofi Aventis Deutschland GmbH
65926 Frankfurt am Main
3. WIRTH Klaus
c/o Sanofi Aventis Deutschland GmbH
65926 Frankfurt am Main
4. SCHREUDER Herman
c/o Sanofi Aventis Deutschland GmbH
65926 Frankfurt am Main
5. BUNING Christian
c/o Sanofi Aventis Deutschland GmbH
65926 Frankfurt am Main
Specification
soft copies attached in pdf
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 4879-CHENP-2013 POWER OF ATTORNEY 21-06-2013.pdf | 2013-06-21 |
| 1 | 4879-CHENP-2013-AbandonedLetter.pdf | 2018-10-04 |
| 2 | 4879-CHENP-2013-FER.pdf | 2018-02-28 |
| 2 | 4879-CHENP-2013 FORM-5 21-06-2013.pdf | 2013-06-21 |
| 3 | 4879-CHENP-2013.pdf | 2017-06-14 |
| 3 | 4879-CHENP-2013 FORM-3 21-06-2013.pdf | 2013-06-21 |
| 4 | abstract 4789-CHENP-2013.jpg | 2014-12-09 |
| 4 | 4879-CHENP-2013 FORM-2 FIRST PAGE 21-06-2013.pdf | 2013-06-21 |
| 5 | 4879-CHENP-2013 FORM-1 21-06-2013.pdf | 2013-06-21 |
| 5 | 4879-CHENP-2013 CORRESPONDENCE OTHERS 11-12-2013.pdf | 2013-12-11 |
| 6 | 4879-CHENP-2013 CORRESPONDENCE OTHERS 21-06-2013.pdf | 2013-06-21 |
| 6 | 4879-CHENP-2013 FORM-3 11-12-2013.pdf | 2013-12-11 |
| 7 | 4879-CHENP-2013 CLAIMS SIGNATURE LAST PAGE 21-06-2013.pdf | 2013-06-21 |
| 7 | 4879 PCTPUBLICATION 21-06-2013.pdf | 2013-06-21 |
| 8 | 4879-CHENP-2013 DESCRIPTION (COMPLETE) 21-06-2013.pdf | 2013-06-21 |
| 8 | 4879-CHENP-2013 CLAIMS 21-06-2013.pdf | 2013-06-21 |
| 9 | 4879-CHENP-2013 DESCRIPTION (COMPLETE) 21-06-2013.pdf | 2013-06-21 |
| 9 | 4879-CHENP-2013 CLAIMS 21-06-2013.pdf | 2013-06-21 |
| 10 | 4879 PCTPUBLICATION 21-06-2013.pdf | 2013-06-21 |
| 10 | 4879-CHENP-2013 CLAIMS SIGNATURE LAST PAGE 21-06-2013.pdf | 2013-06-21 |
| 11 | 4879-CHENP-2013 CORRESPONDENCE OTHERS 21-06-2013.pdf | 2013-06-21 |
| 11 | 4879-CHENP-2013 FORM-3 11-12-2013.pdf | 2013-12-11 |
| 12 | 4879-CHENP-2013 FORM-1 21-06-2013.pdf | 2013-06-21 |
| 12 | 4879-CHENP-2013 CORRESPONDENCE OTHERS 11-12-2013.pdf | 2013-12-11 |
| 13 | abstract 4789-CHENP-2013.jpg | 2014-12-09 |
| 13 | 4879-CHENP-2013 FORM-2 FIRST PAGE 21-06-2013.pdf | 2013-06-21 |
| 14 | 4879-CHENP-2013.pdf | 2017-06-14 |
| 14 | 4879-CHENP-2013 FORM-3 21-06-2013.pdf | 2013-06-21 |
| 15 | 4879-CHENP-2013-FER.pdf | 2018-02-28 |
| 15 | 4879-CHENP-2013 FORM-5 21-06-2013.pdf | 2013-06-21 |
| 16 | 4879-CHENP-2013-AbandonedLetter.pdf | 2018-10-04 |
| 16 | 4879-CHENP-2013 POWER OF ATTORNEY 21-06-2013.pdf | 2013-06-21 |
Search Strategy
| 1 | 4879_19-02-2018.pdf |